Researchers at the University of Western Ontario say they’re confident their HIV vaccine is only months away from being approved for human trials.
According to a report by the National Post, lead researcher Dr. Chil-Yong Kang said the approval from the U.S. Food and Drug Administration can come as soon as two or three months.
The vaccine was submitted recently to the U.S. for approval because that country already has established systems in place to check out vaccines, Dr. Kang said. If approved there, he added, worldwide acceptance of the drug will quickly follow.
There are also more HIV-positive patients in the U.S. than in Canada, which will make it easier to do a human trial comparing how the vaccine attacks the virus in volunteers.
Dr. Kang, 65, admits that it will still “take years” before results from human trials can be completed.
Filed under: Public health | Tagged: AIDS, Innovation
